Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation

Journal of Immunology

Volumn 184, Issue 4, 2010, Pages 1931-1945

  Pedersen, Martin Bjerregård ^a   Zhou, Xingfei ^a   Larsen, Esben Kjær Unmack ^a   Sørensen, Uffe Skov ^a   Kjems, Jørgen ^a   Nygaard, Jens Vinge ^a   Nyengaard, Jens Randel ^a   Meyer, Rikke Louise ^a   Boesen, Thomas ^a   Vorup Jensen, Thomas ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; IMMUNOGLOBULIN M; NANOPARTICLE; PEPTIDOGLYCAN; BACTERIAL ANTIGEN; COMPLEMENT COMPONENT C3; FERRIC ION; FERRIC OXIDE; IMMUNOGLOBULIN G;

ARTICLE; BACTERIAL GROWTH; COMPLEMENT ACTIVATION; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; CULTURE MEDIUM; IMMUNE RESPONSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; ANTIBODY COMBINING SITE; ATOMIC FORCE MICROSCOPY; CHEMISTRY; COMPARATIVE STUDY; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; METABOLISM; SURFACE PROPERTY; ULTRASTRUCTURE;

ANTIGENS, BACTERIAL; BINDING SITES, ANTIBODY; COMPLEMENT C3; COMPLEMENT PATHWAY, CLASSICAL; DEXTRANS; FERRIC COMPOUNDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICROSCOPY, ATOMIC FORCE; NANOPARTICLES; PARTICLE SIZE; PEPTIDOGLYCAN; PROTEIN BINDING; STAPHYLOCOCCUS AUREUS; SURFACE PROPERTIES;

EID: 77949877464     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902214     Document Type: Article

References (48)

1. Sjöberg, A. P., L. A. Trouw, and A. M. Blom. 2009. Complement activation and inhibition: a delicate balance. Trends Immunol. 30: 83-90.
2. Dong, M., S. Xu, C. L. Oliveira, J. S. Pedersen, S. Thiel, F. Besenbacher, and T. Vorup-Jensen. 2007. Conformational changes in mannan-binding lectin bound to ligand surfaces. J. Immunol. 178: 3016-3022. (Pubitemid 46333181)
3. Wallis, R. 2007. Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway. Immunobiology 212: 289-299.
4. Gaboriaud, C., N. M. Thielens, L. A. Gregory, V. Rossi, J. C. Fontecilla-Camps, and G. J. Arlaud. 2004. Structure and activation of the C1 complex of complement: unraveling the puzzle. Trends Immunol. 25: 368v373.
5. Gros, P., F. J. Milder, and B. J. Janssen. 2008. Complement driven by conformational changes. Nat. Rev. Immunol. 8: 48-58.
6. Lo Conte, L., C. Chothia, and J. Janin. 1999. The atomic structure of proteinprotein recognition sites. J. Mol. Biol. 285: 2177-2198.
7. Perkins, S. J., A. S. Nealis, B. J. Sutton, and A. Feinstein. 1991. Solution structure of human and mouse immunoglobulin M by synchrotron X-ray scattering and molecular graphics modelling. A possible mechanism for complement activation. J. Mol. Biol. 221: 1345-1366.
8. Roux, K. H. 1999. Immunoglobulin structure and function as revealed by electron microscopy. Int. Arch. Allergy Immunol. 120: 85-99.
9. Feinstein, A., E. A. Munn, and N. E. Richardson. 1971. The three-dimensional conformation of M and A globulin molecules. Ann. N. Y. Acad. Sci. 190: 104-121.
10. Feinstein, A., and E. A. Munn. 1969. Conformation of the free and antigenbound IgM antibody molecules. Nature 224: 1307-1309.
11. Carballido-López, R., and A. Formstone. 2007. Shape determination in Bacillus subtilis. Curr. Opin. Microbiol. 10: 611-616.
12. Giesbrecht, P., T. Kersten, H. Maidhof, and J. Wecke. 1998. Staphylococcal cell wall: morphogenesis and fatal variations in the presence of penicillin. Microbiol. Mol. Biol. Rev. 62: 1371-1414.
13. Cloud-Hansen, K. A., S. B. Peterson, E. V. Stabb, W. E. Goldman, M. J. McFall-Ngai, and J. Handelsman. 2006. Breaching the great wall: peptidoglycan and microbial interactions. Nat. Rev. Microbiol. 4: 710-716.
14. Pamer, E. G. 2007. Immune responses to commensal and environmental microbes. Nat. Immunol. 8: 1173-1178.
15. Wilkinson, B. J., Y. Kim, and P. K. Peterson. 1981. Factors affecting complement activation by Staphylococcus aureus cell walls, their components, and mutants altered in teichoic acid. Infect. Immun. 32: 216-224.
16. Pinegin, B. V., A. V. Kulakov, E. A. Makarov, P. W. Ledger, and R. M. Khaitov. 1995. The occurrence of natural antibodies to minimal component of bacterial cell wall (N-acetylglucosaminyl-N-acetylmuramyl dipeptide) in sera from healthy humans. Immunol. Lett. 47: 33-37.
17. Spitznagel, J. K., K. J. Goodrum, D. J. Warejcka, J. L. Weaver, H. L. Miller, and L. Babcock. 1986. Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls. Infect. Immun. 52: 803-811.
18. Thiel, S., M. Møller-Kristensen, L. Jensen, and J. C. Jensenius. 2002. Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 205: 446-454. (Pubitemid 35153960)
19. Coligan, J. E., B. E. Bierer, D. H. Margulies, E. M. Shevach, and W. Stober, eds 2005. Current Protocols in Immunology. John Wiley & Sons, Inc., New York.
20. Platts-Mills, T. A., and K. Ishizaka. 1974. Activation of the alternate pathway of human complements by rabbit cells. J. Immunol. 113: 348-358.
21. Czop, J. K., and K. F. Austen. 1985. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor. J. Immunol. 135: 3388-3393.
22. Brown, W. 1993. Dynamic Light Scattering: The Method and Some Applications. Clarendon Press, Oxford.
23. Anastase, S., D. Letourneur, and J. Jozefonvicz. 1996. Affinity chromatography of human anti-dextran antibodies. Isolation of two distinct populations. J. Chromatogr. B Biomed. Appl. 686: 141-150.
24. Karakawa, W. F., and W. F. Vann. 1982. Capsular Polysaccharides of Staphylococcus aureus. Thieme Stratton Inc., New York.
25. Skov Sørensen, U. B., J. Blom, A. Birch-Andersen, and J. Henrichsen. 1988. Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigen in pneumococci. Infect. Immun. 56: 1890-1896.
26. Edwards, C. H., and D. E. Penney. 2006. Calculus. Prentice-Hall Intermational, Inc., Englewood Cliffs, NJ.
27. Stewart, J. 2007. Calculus. Brooks Cole, Pacific Grove, CA.
28. Al-Hanbali, O., K. J. Rutt, D. K. Sarker, A. C. Hunter, and S. M. Moghimi. 2006. Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. J. Nanosci. Nanotechnol. 6: 3126-3133.
29. Moghimi, S. M., A. C. Hunter, C. M. Dadswell, S. Savay, C. R. Alving, and J. Szebeni. 2004. Causative factors behind poloxamer 188 (Pluronic F68, Flocor)-induced complement activation in human sera. A protective role against poloxamer-mediated complement activation by elevated serum lipoprotein levels. Biochim. Biophys. Acta 1689: 103-113.
30. Vonarbourg, A., C. Passirani, P. Saulnier, and J. P. Benoit. 2006. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 27: 4356-4373.
31. Lind, K., M. Kresse, N. P. Debus, and R. H. Müller. 2002. A novel formulation for superparamagnetic iron oxide (SPIO) particles enhancing MR lymphography: comparison of physicochemical properties and the in vivo behaviour. J. Drug Target. 10: 221-230.
32. Burger, R., G. Zilow, A. Bader, A. Friedlein, and W. Naser. 1988. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential. J. Immunol. 141: 553-558.
33. Vorup-Jensen, T., E. S. Sørensen, U. B. Jensen, W. Schwaeble, T. Kawasaki, Y. Ma, K. Uemura, N. Wakamiya, Y. Suzuki, T. G. Jensen, et al. 2001. Recombinant expression of human mannan-binding lectin. Int. Immunopharmacol. 1: 677-687.
34. Scheffers, D. J., and M. G. Pinho. 2005. Bacterial cell wall synthesis: new insights from localization studies. Microbiol. Mol. Biol. Rev. 69: 585-607.
35. Borsos, T., and H. J. Rapp. 1965. Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte. J. Immunol. 95: 559-566.
36. Simberg, D., J. H. Park, P. P. Karmali, W. M. Zhang, S. Merkulov, K. McCrae, S. N. Bhatia, M. Sailor, and E. Ruoslahti. 2009. Differential proteomics analysis of the surface heterogeneity of dextran iron oxide nanoparticles and the implications for their in vivo clearance. Biomaterials 30: 3926-3933.
37. Janssen, B. J., A. Christodoulidou, A. McCarthy, J. D. Lambris, and P. Gros. 2006. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444: 213-216.
38. Janssen, B. J., R. J. Read, A. T. Brünger, and P. Gros. 2007. Crystallography: crystallographic evidence for deviating C3b structure. Nature 448: E1-E2, discussion E2-E3.
39. Pangburn, M. K., R. D. Schreiber, and H. J. Müller-Eberhard. 1983. C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J. Immunol. 131: 1930-1935.
40. Schuhardt, V. T., T. W. Huber, and L. M. Pope. 1969. Electron microscopy and viability of lysostaphin-induced staphylococcal spheroplasts, protoplast-like bodies, and protoplasts. J. Bacteriol. 97: 396-401.
41. Beveridge, T. J. 1981. Ultrastructure, chemistry, and function of the bacterial wall. Int. Rev. Cytol. 72: 229-317.
42. Touhami, A., M. H. Jericho, and T. J. Beveridge. 2004. Atomic force microscopy of cell growth and division in Staphylococcus aureus. J. Bacteriol. 186: 3286-3295.
43. Park, J. T., and T. Uehara. 2008. How bacteria consume their own exoskeletons (turnover and recycling of cell wall peptidoglycan). Microbiol. Mol. Biol. Rev. 72: 211-227.
44. Cloud-Hansen, K. A., K. T. Hackett, D. L. Garcia, and J. P. Dillard. 2008. Neisseria gonorrhoeae uses two lytic transglycosylases to produce cytotoxic peptidoglycan monomers. J. Bacteriol. 190: 5989-5994.
45. Vance, R. E., R. R. Isberg, and D. A. Portnoy. 2009. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe 6: 10-21.
46. Nizet, V. 2007. Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J. Allergy Clin. Immunol. 120: 13-22.
47. Blom, A. M., T. Hallström, and K. Riesbeck. 2009. Complement evasion strategies of pathogens-acquisition of inhibitors and beyond. Mol. Immunol. 46: 2808-2817.
48. Pettersen, E. F., T. D. Goddard, C. C. Huang, G. S. Couch, D. M. Greenblatt, E. C. Meng, and T. E. Ferrin. 2004. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25: 1605-1612.